皓天策略投资顾问（深圳）有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Treadwell Therapeutics Announces the Appointment of J.D. Mowery, as Chief Operating Officer 2022-04-20 04:30
HUANENG POWER INTERNATIONAL, INC. DOMESTIC ON-GRID ELECTRICITY IN THE FIRST QUARTER OF 2022 INCREASED BY 2. 42% YEAR-ON-YEAR 2022-04-14 23:40
Treadwell Therapeutics and University Health Network Sign Licensing Agreement for pre-clinical biologic and small molecule assets 2022-04-06 20:59
Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US 2022-04-06 20:30
CMGE Announces 2021 Annual Results 2022-04-01 14:00
CPIC Announces 2021 Sustainability Report 2022-03-31 17:38
CPIC Announces 2021 Annual Results 2022-03-28 21:46
HUANENG POWER INTERNATIONAL, INC. NET LOSS ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY IN 2021 AMOUNTED TO RMB 10.636 BILLION YEAR-ON-YEAR DECREASE 547.27% 2022-03-23 01:06
Industry Service Innovation Case Selection Results Released - 11 Cases of "CPIC Service" Like to Mention Four Awards 2022-03-17 17:28
MediTrust Health invited three women who are fighting with diseases to share their views for March 8th Women's Day 2022-03-08 18:22
New Subsidiary, New Advantage 2022-03-02 10:54
Rare Disease Day | With iCare, Love is Not Rare, MediTrust Health - iCare Clover Gives Care and Protection to Rare Disease Patients 2022-03-01 20:05
CPIC Gathers Pace in Serving Asian Games 2022-02-25 17:52
JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA 2022-02-16 18:06
THOROUGH PRACTICE OF ESG CONCEPTS AND STEADY PROMOTION OF THE BIG HEALTH STRATEGY 2022-01-31 21:21
CPIC RANKS FIFTH IN TERMS OF GLOBAL INSURANCE BRAND VALUE 2022-01-31 21:19
Novotech Completes $255M Private Placement Transaction and $505M Refinancing to Accelerate Implementation of Growth Initiatives 2022-01-19 16:38
Treadwell Therapeutics Announces A Presentation at the 2021 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor 2021-12-08 20:00
Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257 2021-11-30 20:00
Tongcheng-Elong Announces 2021Q3 Results Securing the Leadership in the Industry and Seizing New Opportunities in the Market 2021-11-22 20:54
1 2 3 4 5